These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5469274)

  • 1. [Pharmacogenetic and interaction-model with some usual antitubercular agents].
    Hanngren A; Boman G; Borgå O; Malmborg AS; Sjöqvist F
    Nord Med; 1970 Sep; 84(38):1204. PubMed ID: 5469274
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symposium: chemotherapy including new antitubercular agents].
    Fukuhara T; Yoshida F; Sasaoka A; Mitsui M
    Kekkaku; 1971 Feb; 46(2):3-4. PubMed ID: 5549795
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
    Tytor IaM
    Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current views on drug treatment of tuberculosis].
    Repo K; Riska N
    Duodecim; 1970; 86(21):1268-78. PubMed ID: 5490929
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption of sulphonamides and antitubercular drugs from the rat lung.
    Burton JA; Schanker LS
    Xenobiotica; 1974 May; 4(5):291-6. PubMed ID: 4407063
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylation of p-aminosalicylic acid and isoniazid in the perfused liver as a competitive enzymatic process].
    Wagner J; Dolezal V
    Acta Univ Carol Med (Praha); 1965; ():Suppl 21:165+. PubMed ID: 5880954
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
    Sabula MM
    Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
    Savula MM
    Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acetylation phenotype and biotransformation of various drugs].
    Grygorowicz J; Januszko J
    Wiad Lek; 1987 Mar; 40(5):319-23. PubMed ID: 3303698
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacokinetics of isoniazid, PAS, and cycloserin in acute and chronic alcoholic intoxication (experimental study)].
    Ortenberg ZA
    Probl Tuberk; 1978 Sep; (9):60-4. PubMed ID: 568263
    [No Abstract]   [Full Text] [Related]  

  • 14. [New drugs in the treatment of primary tuberculosis].
    Gerbeaux J; Hanoteau J
    Ann Pediatr (Paris); 1970 Oct; 17(10):638-43. PubMed ID: 5475417
    [No Abstract]   [Full Text] [Related]  

  • 15. Assay of antituberculosis drugs in tuberculous patients.
    Kent DC
    Dis Chest; 1966 Jun; 49(6):595-9. PubMed ID: 5935729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Concentration of tubazid, PAS and streptomycin in the blood and lung tissue in standard and intravenous administration].
    Kovalenko NN
    Vrach Delo; 1969 Oct; 10():134-5. PubMed ID: 5366785
    [No Abstract]   [Full Text] [Related]  

  • 17. Interference of isonicotinyl hydrazone in the microbiological analysis of rifampicin from anti-tuberculosis FDC products containing isoniazid.
    Mariappan TT; Geetha T; Pandey R; Jindal KC; Singh S
    J Pharm Biomed Anal; 2004 Nov; 36(3):643-7. PubMed ID: 15522543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 19. [New findings in the biotransformation and pharmacokinetics of antitubercular agents].
    Ritter W
    Prax Pneumol; 1973 Mar; 27(3):139-45. PubMed ID: 4121631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].
    Kislitsyna NA; Kotova NI
    Probl Tuberk; 1980 Aug; (8):63-5. PubMed ID: 7403052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.